Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.395 USD | +1.91% | +6.40% | +92.80% |
16/04 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
16/04 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.80% | 30.28M | |
+25.88% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+19.08% | 332B | |
+3.27% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.20% | 145B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience : Closes $11 Million Public Offering